In Bloomberg Law, Joshua Oyster Discusses How Drugmakers Are Fighting Against Weight-Loss Knockoffs

In The News
November 1, 2023
Attorneys:

In a Bloomberg Law article, life sciences regulatory & compliance partner Joshua Oyster discussed how the booming market for drugs to treat diabetes and weight loss has triggered lawsuits and complaints from drugmakers and the Food and Drug Administration targeting companies selling unauthorized versions of the products.

“Some of these situations can be a bit of a whack-a-mole game, where there may not be just one entity that is doing this and making an alleged knockoff … there may be a handful or a dozen,” Joshua said.